⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001630850

Breum Casper

Reports to the SEC for 1 company · COPENHAGEN, G7

Transactions

8

Companies

1

Filings

2

CIK

0001630850

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-05	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,073 sh	—	—	6,073
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+289K sh	—	—	289,102
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+179K sh	—	—	468,552
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+409K sh	—	—	877,489
2017-11-06	SPROSpero Therapeutics, Inc.P Purchase	Director	PPurchase	+214K sh	$14.00	+$3M	1,091,774
2017-11-06	SPROSpero Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−1.15M sh	—	—	0
2017-11-06	SPROSpero Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−682K sh	—	—	0
2017-11-06	SPROSpero Therapeutics, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−2.49M sh	—	—	0

Recent filings

2

Accepted (ET)
Jun 64
Breum Casper0000899243-18-015327
SEC(opens sec.gov)
Nov 74
Breum Casper0000899243-17-025505
SEC(opens sec.gov)

Companies

1

Spero Therapeutics, Inc.DirectorSPRO

Address

C/O LUNDBECKFOND INVEST A/S SCHERFIGSVEJ 7

COPENHAGEN, G7, DK-2100